share_log

6-K: Dupixent Approved in the EU as the First and Only Medicine for Young Children with Eosinophilic Esophagitis

6-K: Dupixent Approved in the EU as the First and Only Medicine for Young Children with Eosinophilic Esophagitis

6-K:Dupixent在歐盟獲批成為首個也是唯壹壹個治療兒童嗜酸細胞性食管炎的藥物
美股SEC公告 ·  2024/11/07 11:38
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息